NeRRe Therapeutics’ £20 Million Series B2 Financing Round

Osborne Clarke advised NeRRe Therapeutics on the deal.The financing involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners and…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now